COZADD BRUCE C — SEC Form 4 filings
SEC reporting owner CIK 1193210. 32 Form 4 filings on record with FilingPulse; latest filed 2026-09-02.
Transaction summary — filings shown
Covers all 32 filings on record, filed 2024-01-19 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 36 legs across 21 filings — 167,500 shares, $30,270,109 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
- Largest priced transaction: sale of 38,126 shares @ $177.27 ($6,758,672) in Jazz Pharmaceuticals plc, filed 2025-12-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | Director | 30 | — | 36 legs · 167,500 sh · $30,270,109 | 20 |
| ACELYRIN, Inc. (SLRN) | Director | 2 | — | — | 4 |
Form 4 filings — COZADD BRUCE C
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 10 @ $244.06 · Tax withholding (F): 1,209 @ $241.39 · Sale (S): 6,000 @ $250.13 | EDGAR |
| 2026-08-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 1,605 @ $0 | EDGAR |
| 2026-08-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 6,000 @ $252.98 | EDGAR |
| 2026-07-06 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 6,000 @ $240.47 | EDGAR |
| 2026-06-03 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 6,000 @ $235.12 | EDGAR |
| 2026-05-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 6,000 @ $203.33 | EDGAR |
| 2026-04-03 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 3,684 @ $190.22 · Sale (S): 2,292 @ $190.94 · Sale (S): 24 @ $191.74 | EDGAR |
| 2026-03-09 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 15,114 @ $188.69 | EDGAR |
| 2026-03-04 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 3,159 @ $186.09 · Sale (S): 2,608 @ $186.73 · Sale (S): 233 @ $187.84 | EDGAR |
| 2026-01-21 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 35,917 @ $0 · Tax withholding (F): 17,453 @ $171.16 | EDGAR |
| 2025-12-01 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Option exercise (M): 76,689 @ $123.36 · Option exercise (M): 811 @ $123.36 · Sale (S): 30,487 @ $178.06 · Sale (S): 8,380 @ $179.23 · Sale (S): 507 @ $179.79 · Sale (S): 38,126 @ $177.27 · +2 more | EDGAR |
| 2025-11-20 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 3,384 @ $180.09 · Sale (S): 8,382 @ $180.88 · Sale (S): 5,517 @ $181.81 · Sale (S): 717 @ $182.60 · Grant/award (A): 2,506 @ $0 | EDGAR |
| 2025-10-03 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 2,000 @ $131.78 · Sale (S): 3,500 @ $140 | EDGAR |
| 2025-09-17 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 15,647 @ $126.16 | EDGAR |
| 2025-09-04 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 3,000 @ $127.23 · Sale (S): 3,000 @ $130 | EDGAR |
| 2025-08-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,000 @ $113.21 | EDGAR |
| 2025-07-03 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 500 @ $105.26 · Sale (S): 500 @ $110 | EDGAR |
| 2025-06-04 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 500 @ $107.90 · Sale (S): 500 @ $110 | EDGAR |
| 2025-05-23 | 4 | ACELYRIN, Inc. (SLRN) | Disposition to issuer (D): 183,434 (derivative) · Disposition to issuer (D): 23,243 (derivative) · Disposition to issuer (D): 92,158 (derivative) | EDGAR |
| 2025-05-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,000 @ $116.35 · Sale (S): 500 @ $120 | EDGAR |
| 2025-04-03 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,500 @ $123.75 | EDGAR |
| 2025-03-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Disposition to issuer (D): 22,251 @ $138.95 | EDGAR |
| 2025-03-03 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 30,814 @ $0 · Sale (S): 6,500 @ $144.25 | EDGAR |
| 2025-02-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,500 @ $122.31 | EDGAR |
| 2025-01-22 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 29,559 @ $0 · Tax withholding (F): 13,840 @ $122.62 | EDGAR |
| 2025-01-06 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,500 @ $123.43 | EDGAR |
| 2024-12-04 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 2,000 @ $121.17 | EDGAR |
| 2024-11-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,000 @ $110.84 | EDGAR |
| 2024-06-11 | 4 | ACELYRIN, Inc. (SLRN) | Grant/award (A): 92,158 (derivative) @ $0 | EDGAR |
| 2024-03-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 22,436 @ $117.53 | EDGAR |
| 2024-03-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 50,187 @ $0 | EDGAR |
| 2024-01-19 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 26,545 @ $0 · Tax withholding (F): 12,245 @ $119.13 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1193210 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →